- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Entrada Therapeutics Inc (TRDA)
Entrada Therapeutics Inc stock price live, this page displays NASDAQ TRDA stock exchange data. View the TRDA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Entrada Therapeutics Inc real time stock price chart below.
What Is the Entrada Therapeutics Inc Stock Price Today?
The Entrada Therapeutics Inc stock price today is 6.75.
What Is the Stock Symbol for Entrada Therapeutics Inc?
The stock symbol for Entrada Therapeutics Inc is "TRDA."
What Stock Exchange Does Entrada Therapeutics Inc Trade On?
Entrada Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Entrada Therapeutics Inc a Good Stock to Buy?
Determining whether Entrada Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRDA quote. (ISIN: US29384C1080)
What Is the Entrada Therapeutics Inc Stock Price Today?
The Entrada Therapeutics Inc stock price today is 6.75.
What Is the Stock Symbol for Entrada Therapeutics Inc?
The stock symbol for Entrada Therapeutics Inc is "TRDA."
What Stock Exchange Does Entrada Therapeutics Inc Trade On?
Entrada Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Entrada Therapeutics Inc a Good Stock to Buy?
Determining whether Entrada Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRDA quote. (ISIN: US29384C1080)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.60
6.89
52 wk Range
5.08
16.45
TRDA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.606.89
52 wk Range
5.0816.45
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TRDA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
19.00
Upside
+181.48%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 19.00
(+181.48% Upside)
Earnings
Latest Release
Aug 05, 2026
EPS / Forecast
-1.01 / -1.05
Revenue / Forecast
898K / 2.23M
Compare TRDA to Peers and Sector
Metrics to compare | TRDA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTRDAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.5x | −8.3x | −0.4x | |
PEG Ratio | 0.01 | 0.12 | 0.00 | |
Price/Book | 1.0x | 4.0x | 2.6x | |
Price / LTM Sales | 51.9x | 71.8x | 3.0x | |
Upside (Analyst Target) | 181.5% | 67.5% | 54.5% | |
Fair Value Upside | Unlock | −7.7% | 7.2% | Unlock |
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company’s Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Entrada Therapeutics (TRDA) Stock Price Today?
The Entrada Therapeutics stock price today is 6.75 USD.
What Stock Exchange Does Entrada Therapeutics Trade On?
Entrada Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Entrada Therapeutics?
The stock symbol for Entrada Therapeutics is "TRDA."
What Is the Entrada Therapeutics Market Cap?
As of today, Entrada Therapeutics market cap is 243.38M USD.
What Is Entrada Therapeutics's Earnings Per Share (TTM)?
The Entrada Therapeutics EPS (TTM) is -3.97.
When Is the Next Entrada Therapeutics Earnings Date?
Entrada Therapeutics will release its next earnings report on Nov 10, 2026.
From a Technical Analysis Perspective, Is TRDA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Entrada Therapeutics Stock Split?
Entrada Therapeutics has split 0 times.
How Many Employees Does Entrada Therapeutics Have?
Entrada Therapeutics has 152 employees.
What is the current trading status of Entrada Therapeutics (TRDA)?
As of Sep 20, 2026, Entrada Therapeutics (TRDA) is trading at a price of 6.75 USD, with a previous close of 6.75 USD. The stock has fluctuated within a day range of 6.60 USD to 6.89 USD, while its 52-week range spans from 5.08 USD to 16.45 USD.
What Is Entrada Therapeutics (TRDA) Price Target According to Analysts?
The average 12-month price target for Entrada Therapeutics is 19.00 USD, with a high estimate of 25 USD and a low estimate of 11 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +181.48% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.